top of page
Home
Our Science
Astatine-211 Targeted Alpha Therapies
FLEX-NK Bifunctional Antibodies
Our Team
News & Resources
Media
Contact Us
Pioneering The Next Generation of Cancer Therapies
NEWS & EVENTS
NAYA to Present at Network for Optimized Astatine-Labeled Radiopharmaceuticals (NOAR) Europe
Annual Meeting
November 4th, 2025
NAYA Announces Partnership with Alpha Nuclide to Support Clinical Development
in China for Its GPC3-Targeting Astatine-211 Alpha Therapy for HCC
October 13th, 2025
NAYA to Partner With Atley Solutions To Accelerate The Development of Its Astatine-211 Radiopharmaceuticals
September 2nd, 2025
bottom of page
